Nucleus Pulposus Allograft

· VIVEX Biologics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nucleus Pulposus Allograft, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease [NA]

See pricing